Acrivon Therapeutics (ACRV) Enterprise Value: -14.15M

Acrivon Therapeutics, Inc. (ACRV)

1.75 +0.03 (+1.74%) USD | NASDAQ | Oct 15, 15:56

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2022. Start Trial.

Date	Value
October 14, 2026	-14.15M
October 13, 2026	-12.86M
October 12, 2026	-6.434M
October 09, 2026	-6.006M
October 08, 2026	-7.720M
October 07, 2026	-7.291M
October 06, 2026	-8.148M
October 05, 2026	-3.006M
October 02, 2026	-2.578M
October 01, 2026	-1.721M
September 30, 2026	-0.0072M
September 29, 2026	1.278M
September 28, 2026	0.4212M
September 25, 2026	2.135M
September 24, 2026	2.992M
September 23, 2026	0.4212M
September 22, 2026	4.278M
September 21, 2026	-1.721M
September 18, 2026	-8.577M
September 17, 2026	-15.00M
September 16, 2026	-15.00M
September 15, 2026	-9.434M
September 14, 2026	-3.864M
September 11, 2026	-2.150M
September 10, 2026	-0.4357M

Date	Value
September 09, 2026	-2.578M
September 08, 2026	2.135M
September 04, 2026	3.420M
September 03, 2026	0.4212M
September 02, 2026	4.278M
September 01, 2026	0.8497M
August 31, 2026	1.707M
August 28, 2026	0.4212M
August 27, 2026	4.278M
August 26, 2026	1.278M
August 25, 2026	5.563M
August 24, 2026	6.420M
August 21, 2026	6.848M
August 20, 2026	6.420M
August 19, 2026	14.56M
August 18, 2026	-0.0072M
August 17, 2026	-0.0072M
August 14, 2026	-4.292M
August 13, 2026	-8.577M
August 12, 2026	-14.15M
August 11, 2026	-13.72M
August 10, 2026	-13.29M
August 07, 2026	-13.72M
August 06, 2026	-15.43M
August 05, 2026	-17.57M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks